Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD44: A New Prognostic Marker in Colorectal Cancer?
Ziranu P, Pretta A, Aimola V, Cau F, Mariani S, D'Agata AP, Codipietro C, Rizzo D, Dell'Utri V, Sanna G, Moledda G, Cadoni A, Lai E, Puzzoni M, Pusceddu V, Castagnola M, Scartozzi M, Faa G. Ziranu P, et al. Among authors: scartozzi m. Cancers (Basel). 2024 Apr 19;16(8):1569. doi: 10.3390/cancers16081569. Cancers (Basel). 2024. PMID: 38672650 Free PMC article. Review.
Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer.
Lai E, Liscia N, Donisi C, Mariani S, Tolu S, Pretta A, Persano M, Pinna G, Balconi F, Pireddu A, Impera V, Dubois M, Migliari M, Spanu D, Saba G, Camera S, Musio F, Ziranu P, Puzzoni M, Demurtas L, Pusceddu V, Dettori M, Massa E, Atzori F, Dessì M, Astara G, Madeddu C, Scartozzi M. Lai E, et al. Among authors: scartozzi m. Cancers (Basel). 2020 May 13;12(5):1214. doi: 10.3390/cancers12051214. Cancers (Basel). 2020. PMID: 32413973 Free PMC article. Review.
New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression.
Ziranu P, Aimola V, Pretta A, Dubois M, Murru R, Liscia N, Cau F, Persano M, Deias G, Palmas E, Loi F, Migliari M, Pusceddu V, Puzzoni M, Lai E, Cascinu S, Faa G, Scartozzi M. Ziranu P, et al. Among authors: scartozzi m. Cancers (Basel). 2023 Feb 14;15(4):1212. doi: 10.3390/cancers15041212. Cancers (Basel). 2023. PMID: 36831554 Free PMC article.
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging.
Corrias G, Lai E, Ziranu P, Mariani S, Donisi C, Liscia N, Saba G, Pretta A, Persano M, Fanni D, Spanu D, Balconi F, Loi F, Deidda S, Restivo A, Pusceddu V, Puzzoni M, Solinas C, Massa E, Madeddu C, Gerosa C, Zorcolo L, Faa G, Saba L, Scartozzi M. Corrias G, et al. Among authors: scartozzi m. Cancers (Basel). 2024 Mar 30;16(7):1364. doi: 10.3390/cancers16071364. Cancers (Basel). 2024. PMID: 38611042 Free PMC article. Review.
BRAF-mutant colorectal cancer, a different breed evolving.
Lai E, Pretta A, Impera V, Mariani S, Giampieri R, Casula L, Pusceddu V, Coni P, Fanni D, Puzzoni M, Demurtas L, Ziranu P, Faa G, Scartozzi M. Lai E, et al. Among authors: scartozzi m. Expert Rev Mol Diagn. 2018 Jun;18(6):499-512. doi: 10.1080/14737159.2018.1470928. Epub 2018 May 9. Expert Rev Mol Diagn. 2018. PMID: 29708446 Review.
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy.
Giampieri R, Ziranu P, Daniele B, Zizzi A, Ferrari D, Lonardi S, Zaniboni A, Cavanna L, Rosati G, Casagrande M, Pella N, Demurtas L, Zampino MG, Sozzi P, Pusceddu V, Germano D, Lai E, Zagonel V, Codecà C, Libertini M, Puzzoni M, Labianca R, Cascinu S, Scartozzi M. Giampieri R, et al. Among authors: scartozzi m. Cancers (Basel). 2020 May 22;12(5):1330. doi: 10.3390/cancers12051330. Cancers (Basel). 2020. PMID: 32456056 Free PMC article.
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors.
Ziranu P, Pretta A, Pozzari M, Maccioni A, Badiali M, Fanni D, Lai E, Donisi C, Persano M, Gerosa C, Puzzoni M, Bardanzellu F, Ambu R, Pusceddu V, Dubois M, Cerrone G, Migliari M, Murgia S, Spanu D, Pretta G, Aimola V, Balconi F, Murru S, Faa G, Scartozzi M. Ziranu P, et al. Among authors: scartozzi m. Sci Rep. 2023 Mar 16;13(1):4397. doi: 10.1038/s41598-023-31538-3. Sci Rep. 2023. PMID: 36928082 Free PMC article.
Immunotherapy and Cancer: The Multi-Omics Perspective.
Donisi C, Pretta A, Pusceddu V, Ziranu P, Lai E, Puzzoni M, Mariani S, Massa E, Madeddu C, Scartozzi M. Donisi C, et al. Among authors: scartozzi m. Int J Mol Sci. 2024 Mar 21;25(6):3563. doi: 10.3390/ijms25063563. Int J Mol Sci. 2024. PMID: 38542536 Free PMC article. Review.
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients.
Puzzoni M, Ziranu P, Demurtas L, Lai E, Mariani S, Liscia N, Soro P, Pretta A, Impera V, Camera S, Musio F, Persano M, Donisi C, Tolu S, Balconi F, Scartozzi M. Puzzoni M, et al. Among authors: scartozzi m. Future Oncol. 2020 Jan;16(2):4337-4339. doi: 10.2217/fon-2019-0624. Epub 2019 Dec 3. Future Oncol. 2020. PMID: 31793396 Free article. No abstract available.
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.
Ziranu P, Lai E, Schirripa M, Puzzoni M, Persano M, Pretta A, Munari G, Liscia N, Pusceddu V, Loupakis F, Demurtas L, Libertini M, Mariani S, Migliari M, Dubois M, Giampieri R, Sotgiu G, Dei Tos AP, Lonardi S, Zaniboni A, Fassan M, Scartozzi M. Ziranu P, et al. Among authors: scartozzi m. Target Oncol. 2021 Jul;16(4):517-527. doi: 10.1007/s11523-021-00816-3. Epub 2021 May 10. Target Oncol. 2021. PMID: 33970400 Free PMC article.
358 results